{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HBV immune tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase of HBV infection.","id":"MTBLS279_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS279","studyUrl":"http://integmet.org/study/MTBLS279","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"64489","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"VXUOFDJKYGDUJI-OAQYLSRUSA-N","pvalue":8.647206419792836e-08,"ratio":2.3117399707142887,"synonym_name":"1-myristoyl-glycero-3-phosphocholine"},{"chebi_id":"131738","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-hydroxy-2-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IGZPHNNYPPAPLA-OAQYLSRUSA-N","pvalue":8.405758691368748e-06,"ratio":2.0937971410244134,"synonym_name":"PC(0:0/14:0)"},{"chebi_id":"131924","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RJZVWDTYEWCUAR-JOCHJYFZSA-N","pvalue":9.223299265247036e-05,"ratio":1.6167745311258164,"synonym_name":"1-Pentadecanoyl-glycero-3-phosphocholine"}],"totalFeatures":11}